R&D JP Morgan 2023 – Alexandre LeVert Editor-in-chief Jonah Comstock caught up with Alexandre LeVert, chairman, CEO, and co-founder of Osivax, on the sidelines of JP Morgan in San Francisco at the beginning of January of this year.&nbs
Events Partner Content 4th Annual Cell Engager Summit | May 24-26 | Boston, MA Learn from the pioneers of immunotherapy
Events Partner Content Cell-Mediated Therapies for Infectious Disease Summit Cell-Mediated Therapies for Infectious Disease Summit
Views & Analysis How T-cell therapy saved my life Judy Perkins’ stage 4 cancer was eradicated after she joined a clinical trial for T-cell therapy.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.